IP Verse

Sanofi Aventis Deutschland vs. Amgen - UPC_CFI_1/2023

The case UPC_CFI_1/2023 was filed by the plaintiff Sanofi Aventis Deutschland against the defendant Amgen on 02 Jun, 2023. The case decision was made on Jan 24, 2024.

Case Timeline

02 Jun, 2023
Case Filed
02 Jun, 2023
Counterclaim for Revocation
27 Nov, 2023
Written Procedure
13 Dec, 2023
Rejoinder
13 Dec, 2023
Interim Conference
13 Dec, 2023
Oral Procedure
Jan 24, 2024
Decision

Case Details

    Case Number:

    UPC_CFI_1/2023

    Patent Number:

    EP3666797

    Filing Date:

    02 Jun, 2023

    Proceeding Type:

    Revocation

    Case Phase:

    Case Closed

    Plaintiffs:

    • Sanofi Aventis Deutschland

    Plaintiff Representative:

    • Daniel Wise

    Defendants:

    • Amgen

    Defendant Representative:

    • Koen Bijvank

    Judges:

    • Andras Kupecz
    • Casper Struve
    • Ulrike Voß

    Court Division:

    First Instance, Central Division - Munich

Case Decision

    Decision Date:

    Jan 24, 2024

    Decision Document:

    View document

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Oct 23, 2024Procedural Order App 47172
Oct 23, 2024Procedural Order App 47163
Jul 16, 2024Final Order Anonymised
Jul 16, 2024Decision Revocation Action 1
Jul 16, 2024Decisionoutcome
Jul 4, 2024Announcement
Jun 5, 2024Oral Hearing Referencing 459505
May 22, 2024Interimprocedureclosure
May 13, 2024Receipt
May 10, 2024Amgen Slides
May 10, 2024Amgen R 9 Appl Filing Slides
May 10, 2024.05.10 Sanofi And Regeneron Slides Signed
May 10, 2024.05.10 Sanofi And Regeneron Slide Reference Table Signed
May 10, 2024.05.10 Cover Letter Accompanying Slides Signed
May 7, 2024Receipt
May 7, 2024Outcome Of The Order
May 7, 2024Order Re Admission Of Documents
May 7, 2024Extension Order Slides
May 6, 2024Extension Request
May 3, 2024Amgen Reply To Prel Order 30 April
Apr 30, 2024Po
Apr 30, 2024Outcome Of The Order
Apr 30, 2024Order Closing Workflow
Apr 26, 2024Receipt
Apr 26, 2024C54A Amgen Infringement Claim (En Translation)
Apr 26, 2024C37A US60 818234 (Priority Document To Bms Patent Application) (Signed)
Apr 26, 2024Annex 1 Updated Consolidated List Of Exhibits And Evidence (Signed)
Apr 26, 2024.04.26 Rop 9.1 Application Re C37A (Signed)
Apr 19, 2024Writtenprocedureclosure
Apr 19, 2024Summons Oral Hearing
Apr 19, 2024Summons
Apr 19, 2024Hearing Dates
Apr 5, 2024Receipt
Apr 5, 2024Case Summary
Apr 5, 2024Annex 2 Notice Of Experts (Signed)
Apr 5, 2024Annex 1 CR OSS Reference Table (Signed)
Apr 5, 2024Amgen Response Cd To Sanofi Submission Re Pan Declaration
Apr 5, 2024Amgen Cover Letter Case Summary
Apr 5, 2024.04.05 Claimants Case Summary Signed
Apr 5, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)
Mar 7, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)
Mar 4, 2024Order To Combine Cases Act 459505 And Cc 586764
Feb 27, 2024Order To Combine Cases
Feb 6, 2024Receipt
Feb 5, 2024Order Local Division 2 February
Feb 5, 2024Exhibit
Feb 5, 2024D99 Edrees Et Al
Feb 5, 2024C10A Priority Document
Feb 5, 2024Application For A Procedural Order Pursuant To Rule 9(1) Rop
Feb 5, 2024Application
Jan 24, 2024Rop 9.1 Order Final
Jan 24, 2024Outcome Of The Order
Jan 19, 2024Amgen Response Cd Order Rule 9 Application
Jan 17, 2024Representation
Jan 16, 2024Template Order
Jan 16, 2024Receipt
Jan 16, 2024Preliminary Order 16 January Rop 9
Jan 16, 2024Acknowledgement Of Change Of A Representative
Jan 15, 2024Rejoinder To Reply To Defence To Application To Amend
Jan 15, 2024Rejoinamendpatentdefence
Jan 15, 2024Exhibit E15
Jan 15, 2024Exhibit E14
Jan 15, 2024Exhibit E13
Jan 15, 2024Exhibit C114
Jan 15, 2024Exhibit C113
Jan 15, 2024Exhibit C112
Jan 15, 2024Application
Jan 9, 2024Formal Checks Notification Of Positive Outcome
Jan 9, 2024App R293 Receipt
Dec 22, 2023Explanations Re Application For Change Of Representative (R. 293 Rop)
Dec 22, 2023Acknowledgement Of Lodging
Dec 13, 2023Replyamendpatentdefence
Dec 13, 2023Defendants Reply To Claimants Defence To Application To Amend
Dec 13, 2023Defendants Rejoinder To Reply To Defence (13.12.)
Dec 13, 2023D98 Internal Amgen Research Document ()
Dec 13, 2023D97 Transcript Of Feb 22, Trial Hearing (S. Jackson)
Dec 13, 2023D96 Mgi Mouse Facts
Dec 13, 2023D95 Horton Parker Joint Expert Report
Dec 13, 2023D94 Weider
Dec 13, 2023D93 O. Pan Declaration
Dec 13, 2023D92 US8710192B2 (Novartis)
Dec 13, 2023D91 Lin
Dec 13, 2023D90 Oltersdorf
Dec 13, 2023D89 Wells And Clendon
Dec 13, 2023D88 Arkin And Wells
Dec 13, 2023D87 Wetterau 1998
Dec 13, 2023D86 Benjannet
Dec 13, 2023D85 Abstract Book Pcsk9 Conference Nantes ()
Dec 13, 2023D84 Fraser 1995
Dec 13, 2023D83 Wight And Merrilees
Dec 13, 2023D82 Chan
Dec 13, 2023D81 Prof. Boyd'S Chart From Us Proceedings
Dec 13, 2023D80 Paul
Dec 13, 2023D79 Dubuc
Dec 13, 2023D78 Dunbar
Dec 13, 2023D77 Brunzelle
Dec 13, 2023D76 Hansen
Dec 13, 2023D75 Blundell
Dec 13, 2023D74 Blundell
Dec 13, 2023D73 Manjasetty
Dec 13, 2023D72 Mcpherson
Dec 13, 2023D71 Ladner
Dec 13, 2023D70 Sandin
Dec 13, 2023Annex 1 Updated List Of Cited Documents Defendant Amgen
Dec 13, 2023Acknowledgement Of Lodging
Dec 13, 20232Nd Declaration Of Prof. A. Rees
Dec 13, 20232Nd Declaration Of Dr. R. Parker
Dec 5, 2023Amendpatentdefence
Dec 5, 2023.11.13 Sanofi Cd Reply To Defence Signed
Dec 4, 2023Receipt
Dec 4, 2023Formal Checks Notification Of Positive Outcome
Dec 4, 2023Defendant Amgens Application To Amend (Ar1 Ar17)
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Marked Up Versions)
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Clean Version)
Dec 4, 2023Acknowledgement Of Lodging
Dec 1, 2023Defendants Defence To Revocation (Includes Application To Amend)
Dec 1, 2023Auxiliary Requests Ar1 17 (Marked Up Version)
Dec 1, 2023Auxiliary Requests Ar1 17 (Clean Version)
Nov 27, 2023Outcome Of The Order
Nov 27, 2023Closing Workflow
Nov 22, 2023Rop 9.3(A) Order
Nov 22, 2023Receipt
Nov 22, 2023Outcome Of The Order
Nov 21, 2023Defandants Additional Comments Re Rule 9.3 Rop (Time Extension Request)
Nov 20, 2023Response To Amgen Request 587598 For An Extension To Rejoinder
Nov 20, 2023Preliminary Order Rop 9.3(A)
Nov 17, 2023Response To Amgen Request 587598 For An Extension To Rejoinder
Nov 17, 2023Receipt
Nov 16, 2023Reasoned Request (Time Extension) Pursuant To Rule 9 Rop
Nov 13, 2023E9 Signed
Nov 13, 2023E8 Signed
Nov 13, 2023E7 Signed
Nov 13, 2023E10 Signed
Nov 13, 2023C99 Signed
Nov 13, 2023C98 Signed
Nov 13, 2023C97 Signed
Nov 13, 2023C96 Signed
Nov 13, 2023C95 Signed
Nov 13, 2023C94 Signed
Nov 13, 2023C93 Signed
Nov 13, 2023C92 Signed
Nov 13, 2023C91 Signed
Nov 13, 2023C90 Signed
Nov 13, 2023C89 Signed
Nov 13, 2023C88 Signed
Nov 13, 2023C87 Signed
Nov 13, 2023C86 Signed
Nov 13, 2023C85 Signed
Nov 13, 2023C84 Signed
Nov 13, 2023C83 Signed
Nov 13, 2023C82 Signed
Nov 13, 2023C81 Signed
Nov 13, 2023C80 Signed
Nov 13, 2023C79 Signed
Nov 13, 2023C78 Signed
Nov 13, 2023C77 Signed
Nov 13, 2023C76 Signed
Nov 13, 2023C75 Signed
Nov 13, 2023C74 Signed
Nov 13, 2023C73 Signed
Nov 13, 2023C72 Signed
Nov 13, 2023C71 Signed
Nov 13, 2023C70 Signed
Nov 13, 2023C69 Signed
Nov 13, 2023C68 Signed
Nov 13, 2023C67 Signed
Nov 13, 2023C66 Signed
Nov 13, 2023C65 Signed
Nov 13, 2023C64 Signed
Nov 13, 2023C63 Signed
Nov 13, 2023C62 Signed
Nov 13, 2023C61 Signed
Nov 13, 2023C60 Signed
Nov 13, 2023C59 Signed
Nov 13, 2023C58 Signed
Nov 13, 2023C57 Signed
Nov 13, 2023C56 Signed
Nov 13, 2023C55 Signed
Nov 13, 2023C54 Signed
Nov 13, 2023C38A Signed
Nov 13, 2023C111 Signed
Nov 13, 2023C110 Signed
Nov 13, 2023C109 Signed
Nov 13, 2023C108 Signed
Nov 13, 2023C107 Signed
Nov 13, 2023C106 Signed
Nov 13, 2023C105 Signed
Nov 13, 2023C104 Signed
Nov 13, 2023C103 Signed
Nov 13, 2023C102 Signed
Nov 13, 2023C101 Signed
Nov 13, 2023C100 Signed
Nov 13, 2023Acknowledgement Of Lodging
Nov 13, 2023.11.13 Sanofi Cd Reply To Defence Signed
Oct 16, 2023Order Rop 28 DATED 16 October
Oct 16, 2023Official Date
Oct 11, 2023Reply To Preliminary Order Setting Provisional Dates (Signed)
Oct 9, 2023Defendants Reply To Po No. 577997 (No Objections)
Oct 4, 2023Provisional Date
Oct 4, 2023Preliminary Order Rule 28 Rop
Sep 14, 2023Formal Checks Notification Of Positive Outcome
Sep 14, 2023Acknowledgement Of Lodging
Sep 12, 2023E6 Declaration Of Prof. T. Rees (With Cv)
Sep 12, 2023E5 Declaration Of Dr R. Parker (With Cv)
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iv
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iii
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Ii
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part I
Sep 12, 2023Defendant Amgen'S Defence To Revocation
Sep 12, 2023D9 CR OOKE
Sep 12, 2023D8 Ni Et Al.
Sep 12, 2023D7 Kruth
Sep 12, 2023D6 Wo /057457 A2
Sep 12, 2023D69 Examiner Notes About Irrelevance Of Tpos (March 27,)
Sep 12, 2023D68 Examiner Interview Notes Re Tpos (March 15,)
Sep 12, 2023D67 Examiner Interview Notes (March 1,)
Sep 12, 2023D66 Bell
Sep 12, 2023D65 Subramaniam
Sep 12, 2023D64 Choi
Sep 12, 2023D63 Spencer
Sep 12, 2023D62 Novotny 1983
Sep 12, 2023D61 Jia
Sep 12, 2023D60 Soto
Sep 12, 2023D5 Wo /043753 A2
Sep 12, 2023D59 Hu
Sep 12, 2023D58 Paull
Sep 12, 2023D57 Nature Editorial
Sep 12, 2023D56 Parameswaran And Liu
Sep 12, 2023D55 Rudenko Full Validation Report
Sep 12, 2023D54 Degenst
Sep 12, 2023D53 Pedrioli And Oxenius
Sep 12, 2023D52 Perelson Weisbuch 1995
Sep 12, 2023D51 Raybould
Sep 12, 2023D50 Edwards
Sep 12, 2023D4 Kastelein
Sep 12, 2023D49 Rudenko
Sep 12, 2023D48 Baerga Ortiz
Sep 12, 2023D47 Glaser 1992
Sep 12, 2023D46 Maccallum 1996
Sep 12, 2023D45 Ye
Sep 12, 2023D44 Chowdhury 1999
Sep 12, 2023D43 Roberts 1987
Sep 12, 2023D42 Us 8,357,371 B2
Sep 12, 2023D41 EP2358756B1
Sep 12, 2023D40 Declaration Of Wei Wang
Sep 12, 2023D40B Appendix B Wang Lab Notebook
Sep 12, 2023D40A Appendix A Wang Lab Notebook
Sep 12, 2023D3 Frank Kamenetsky Et Al.
Sep 12, 2023D39 Declaration Of Kelly Berry
Sep 12, 2023D38 Kondrashov
Sep 12, 2023D37 Rees
Sep 12, 2023D36 Baran
Sep 12, 2023D35 Lo Surdo
Sep 12, 2023D34 Eliassen
Sep 12, 2023D33 Esteve
Sep 12, 2023D32 Mitchell
Sep 12, 2023D31 Us 8,420,098 B2
Sep 12, 2023D30 Horton
Sep 12, 2023D2 Us 7,737,266 B2 (Alnylam)
Sep 12, 2023D29 Wo /1057797
Sep 12, 2023D28 Press Release Bms Isis
Sep 12, 2023D27 Poirier
Sep 12, 2023D26 Poirier
Sep 12, 2023D25 Mcnutt
Sep 12, 2023D24 Us /0275053
Sep 12, 2023D23 Grefhorst
Sep 12, 2023D22 Ioannidis
Sep 12, 2023D21 Homer
Sep 12, 2023D20 Nassoury
Sep 12, 2023D1 Seeking Alpha Alnylam
Sep 12, 2023D19 Graham
Sep 12, 2023D18 Seidah
Sep 12, 2023D17 Maxwell
Sep 12, 2023D16 Horton
Sep 12, 2023D15 Lagace Supplemental Data To C3
Sep 12, 2023D14 Havel And Hamilton
Sep 12, 2023D13 Mccuskey
Sep 12, 2023D12 Brown And Goldstein 1979
Sep 12, 2023D11 Brown And Goldstein 1986
Sep 12, 2023D10 Bell
Sep 12, 2023Ar1 Ar17 (Marked Up)
Sep 12, 2023Ar1 Ar17 (Clean Version)
Sep 12, 2023Annex 2 Aso Technology
Sep 12, 2023Annex 1 List Of Cited Documents Defendant Amgen
Aug 24, 2023Preliminary Objection Decisionoutcome
Aug 24, 2023Order Rejecting Preliminary Objection DATED 24 August
Aug 23, 2023554674/Oh/2Mu/Upc202308173Pm
Aug 21, 2023Outcome Of The Order
Aug 21, 2023Order Re 9.3(A) Request Granting 2 Weeks Extension
Aug 21, 2023Comments Pursuant To Rop264
Aug 18, 2023Outcome Of The Order
Aug 18, 2023Order Closing Application
Aug 17, 2023Re Rule 9.3(A) Request Closing This Application
Aug 17, 2023Receipt
Aug 17, 2023Preliminary Order 17 August Rule 9 Application
Aug 17, 2023Outcome Of The Order
Aug 17, 2023Letter Adding Co Representatives 17 Aug (Signed)
Aug 16, 2023Supplementary Submission To Extension Request
Aug 16, 2023Public Attendance Order Hearing
Aug 16, 2023Order Re Public Attendance Po Hearing (Ord 562392 2023)
Aug 16, 2023Order Re Public Attendance Po Hearing
Aug 16, 2023Application
Aug 15, 2023Submission In Reply To Claimants Response To Preliminary Objection (Rule 49.1 Rop)
Aug 15, 2023Reasoned Request Pursuant To Rule 9 Rop
Aug 9, 2023Hearing Invitation 17 August 1500
Aug 9, 2023Hearing Dates
Aug 8, 2023Exhibit CR PO 6B Signed
Aug 8, 2023Exhibit CR PO 6A Signed
Aug 8, 2023Exhibit CR PO 5B Signed
Aug 8, 2023Exhibit CR PO 5A Signed
Aug 8, 2023Exhibit CR PO 4B Signed
Aug 8, 2023Exhibit CR PO 4A Signed
Aug 8, 2023Exhibit CR PO 3 Signed
Aug 8, 2023Exhibit CR PO 2 Signed
Aug 8, 2023Exhibit CR PO 1 Signed
Aug 8, 2023Commentpreliminaryobjection
Aug 8, 2023Comment On Preliminary Objection
Aug 8, 2023Annex To Exhibit CR PO 2 Signed
Aug 4, 2023Template Order
Jul 31, 2023Receipt
Jul 28, 2023.07.28 Withdrawal Of Document Request Action No 459505 Signed Agc
Jul 25, 2023Preliminary Objection Of Defendant (R. 48 And R. 19.1 Rop)
Jul 25, 2023Preliminaryobjection
Jul 25, 2023Formal Checks Request For Correction
Jul 25, 2023Exhibit Ed 2
Jul 25, 2023Exhibit Ed 1
Jul 21, 2023Preliminary Objection According To R. 48 And R 19.1 Rop
Jul 21, 2023Exhibit Ed2
Jul 21, 2023Exhibit Ed1
Jul 17, 2023Formal Checks Request For Correction
Jul 12, 2023Reply Of Defendant (Amgen) To Intended Appointment Of Tqj
Jul 12, 2023Acknowledgement Of Lodging
Jul 5, 2023Acknowledgement Of Adding A Missing Party Or Applicant
Jun 29, 2023Upc Cfi 1 Formal Response To The Procedural Order Of The Court 536514 2023 Dated Signed
Jun 29, 2023Outcome Of The Order
Jun 29, 2023Order Generic Application
Jun 29, 2023Acknowledgement Of Access To Case
Jun 27, 2023Receipt
Jun 23, 2023Rule 9 Order Final
Jun 23, 2023Payment Receipt Signed
Jun 23, 2023P4B 61 086133 Signed
Jun 23, 2023P4A 61 086133 Signed
Jun 23, 2023P3G 61 010630 Signed
Jun 23, 2023P3F 61 010630 Signed
Jun 23, 2023P3E 61 010630 Signed
Jun 23, 2023P3D 61 010630 Signed
Jun 23, 2023P3C 61 010630 Signed
Jun 23, 2023P3B 61 010630 Signed
Jun 23, 2023P3A 61 010630 Signed
Jun 23, 2023P2B 61 008965 Signed
Jun 23, 2023P2A 61 008965 Signed
Jun 23, 2023P1 60 957668 Signed
Jun 23, 2023Notification Of Service
Jun 23, 2023Letter For Service
Jun 23, 2023E4 Zwicker Declaration Signed
Jun 23, 2023E3 Boyd Declaration Cv Signed
Jun 23, 2023E2 Horton Declaration Cv Signed
Jun 23, 2023E1 Schwartz Declaration Citations Signed
Jun 23, 2023C9 Mcnutt Signed
Jun 23, 2023C8 Cunningham Signed
Jun 23, 2023C7 Fisher Signed
Jun 23, 2023C6 Qian Signed
Jun 23, 2023C5 Kwon Signed
Jun 23, 2023C53 European Patent Register For .4 Signed
Jun 23, 2023C52 National Register Extracts Signed
Jun 23, 2023C51 Maggon Signed
Jun 23, 2023C50 Weiner Signed
Jun 23, 2023C4 Zhang Signed
Jun 23, 2023C49 Wo 077854 Signed
Jun 23, 2023C49A US61 168753 Signed
Jun 23, 2023C48 Duff Signed
Jun 23, 2023C47 Glennie And Johnson Signed
Jun 23, 2023C46 Hoogenboom And Chames Signed
Jun 23, 2023C45 Claims Filed In November And Sections Of Response Signed
Jun 23, 2023C44 Claims Filed With Response To Eesr And Sections Of Response Signed
Jun 23, 2023C43 Claims And Accompanying Letter Feb Signed
Jun 23, 2023C42 Zhao Signed
Jun 23, 2023C41 Kuroda Signed
Jun 23, 2023C40 Summary Of European National Case Law On Sufficiency Of Disclosure Signed
Jun 23, 2023C3 Lagace Signed
Jun 23, 2023C39 Brown Goldstein Signed
Jun 23, 2023C38 WO2009055783 Signed
Jun 23, 2023C37B WO2008105797 Signed
Jun 23, 2023C37A WO2008105797 Signed
Jun 23, 2023C36 Seidah Signed
Jun 23, 2023C35 Goldstein Brown 1975 Signed
Jun 23, 2023C34D Turk Signed
Jun 23, 2023C34C Turk Signed
Jun 23, 2023C34B Turk Signed
Jun 23, 2023C34A Turk Signed
Jun 23, 2023C33 Benjannet Signed
Jun 23, 2023C32 Park Signed
Jun 23, 2023C31B Sun Signed
Jun 23, 2023C31A Sun Signed
Jun 23, 2023C30 Berge Signed
Jun 23, 2023C2 Wo 100318 Signed
Jun 23, 2023C2C Gao Signed
Jun 23, 2023C2B Pct Request For C2 Signed
Jun 23, 2023C2A US61 063980 Signed
Jun 23, 2023C29 Abifadel Signed
Jun 23, 2023C28 Cohen Signed
Jun 23, 2023C27 Maxwell Signed
Jun 23, 2023C26 Holla Signed
Jun 23, 2023C25 Rashid Signed
Jun 23, 2023C24B Hoogenboom Signed
Jun 23, 2023C24A Hoogenboom Signed
Jun 23, 2023C23 Antibody Engineering Methods And Protocols Signed
Jun 23, 2023C22 Phage Display A Laboratory Manual Signed
Jun 23, 2023C21 Cameron Signed
Jun 23, 2023C20 Bottomley Signed
Jun 23, 2023C1 Wo 100297 Signed
Jun 23, 2023C1F Ni Signed
Jun 23, 2023C1E Wikipedia Simvastatin Signed
Jun 23, 2023C1D Preliminary Opinion Of The Enlarged Board In G1 22 And G2 22 Signed
Jun 23, 2023C1C Pct Request For C1 Signed
Jun 23, 2023C1B US61 066577 Signed
Jun 23, 2023C1A US61 063949 Signed
Jun 23, 2023C19 Ramasamy Signed
Jun 23, 2023C18 Sarkar Et Al Signed
Jun 23, 2023C17 Seidah And Prat Signed
Jun 23, 2023C16 Cohen Signed
Jun 23, 2023C15 Seidah Signed
Jun 23, 2023C14 Lopez Signed
Jun 23, 2023C13 Hampton Signed
Jun 23, 2023C12 Piper Signed
Jun 23, 2023C11 Horton Signed
Jun 23, 2023C10 Wo 125623 Signed
Jun 23, 2023B1V EP3666797 Signed
Jun 23, 2023B1U EP3666797 Signed
Jun 23, 2023B1T EP3666797 Signed
Jun 23, 2023B1S EP3666797 Signed
Jun 23, 2023B1R EP3666797 Signed
Jun 23, 2023B1Q EP3666797 Signed
Jun 23, 2023B1P EP3666797 Signed
Jun 23, 2023B1O EP3666797 Signed
Jun 23, 2023B1N EP3666797 Signed
Jun 23, 2023B1M EP3666797 Signed
Jun 23, 2023B1L EP3666797 Signed
Jun 23, 2023B1K EP3666797 Signed
Jun 23, 2023B1J EP3666797 Signed
Jun 23, 2023B1I EP3666797 Signed
Jun 23, 2023B1H EP3666797 Signed
Jun 23, 2023B1G EP3666797 Signed
Jun 23, 2023B1F EP3666797 Signed
Jun 23, 2023B1E EP3666797 Signed
Jun 23, 2023B1D EP3666797 Signed
Jun 23, 2023B1C EP3666797 Signed
Jun 23, 2023B1B EP3666797 Signed
Jun 23, 2023B1A EP3666797 Signed
Jun 23, 2023A1F Wo 026558 Pct Application As Filed Signed
Jun 23, 2023A1E Wo 026558 Pct Application As Filed Signed
Jun 23, 2023A1D Wo 026558 Pct Application As Filed Signed
Jun 23, 2023A1C Wo 026558 Pct Application As Filed Signed
Jun 23, 2023A1B Wo 026558 Pct Application As Filed Signed
Jun 23, 2023A1A Wo 026558 Pct Application As Filed Signed
Jun 20, 2023Panel Appointment
Jun 2, 2023Statementofrevocation
Jun 2, 2023Formal Checks Notification Of Positive Outcome
Jun 1, 2023Sanofi V Amgen Revocation Action EP3666797 Signed V2
Jun 1, 2023Letter To Registry Sanofi V Amgen Uploading Issues On Signed
Jun 1, 2023.06.01 Letter To The Upc Lodging Of Revocation Action

More cases involving EP3666797B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_3214/2025Jan 21, 2025Redacted Natural Person NameAmgen, Dehns, Redacted Natural Person Name, Sanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51679/2024Sep 13, 2024AmgenSanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51683/2024Sep 13, 2024AmgenRegeneron Pharmaceuticals

More cases involving Sanofi Aventis Deutschland

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_33148/2025Jul 17, 2025Sanofi Aventis DeutschlandStada Arzneimittel, Stada Nordic, Stadapharm
ORD_22245/2025May 11, 2025Sanofi Aventis DeutschlandAccord Healthcare, Accord Healthcare AB, Accord Healthcare Italia, Accord Healthcare SLU
ORD_22246/2025May 11, 2025Sanofi Aventis DeutschlandBetapharm Arzneimittel, DR Reddys, Reddy Pharma

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -